The government’s top vaccine official, working under Health Secretary Robert F. Kennedy Jr., restricted the approval of two ...

Novavax Inc. closed 60.47% below its 52-week high of $17.81, which the company achieved on July 26th.

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

The stock's fall snapped a three-day winning streak.

A series of new revelations has come to light about the FDA's delay in granting full approval to Novavax's COVID-19 shot, thanks to recent reporting from the Wall Street Journal and STAT News.

Korea has developed the world's first recombinant protein-based anthrax vaccine, a major step toward self-sufficiency that ...

The new Covid variant, officially known as XFG and dubbed Stratus, has become the dominant strain in England within weeks, ...

The first new non-opioid for severe acute pain has been on the market for a few months. But it's a lot more expensive than opioids, and many people can't get it because of spotty insurance coverage.